1403864-74-3 Usage
Uses
Used in Pharmaceutical Industry:
4-Aminobicyclo[2.2.2]octan-1-ol hydrochloride is used as a key intermediate for the synthesis of various drugs, particularly for the development of antipsychotic and antidepressant medications. Its role in the synthesis process is crucial due to its ability to contribute to the formation of the desired active pharmaceutical ingredients.
Used as a Chiral Auxiliary:
In the field of asymmetric synthesis, 4-Aminobicyclo[2.2.2]octan-1-ol hydrochloride is used as a chiral auxiliary to assist in the production of enantiomerically pure compounds. This application is vital for ensuring the desired stereochemistry in the final pharmaceutical product, which can significantly impact the drug's efficacy and safety.
Used in Drug Formulation:
The hydrochloride salt form of 4-Aminobicyclo[2.2.2]octan-1-ol is used to improve the stability and water solubility of pharmaceutical formulations. This enhancement makes the compound easier to handle and administer, which is essential for the development of effective drug delivery systems.
Check Digit Verification of cas no
The CAS Registry Mumber 1403864-74-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,0,3,8,6 and 4 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1403864-74:
(9*1)+(8*4)+(7*0)+(6*3)+(5*8)+(4*6)+(3*4)+(2*7)+(1*4)=153
153 % 10 = 3
So 1403864-74-3 is a valid CAS Registry Number.
1403864-74-3Relevant articles and documents
SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
-
Page/Page column 137, (2012/11/07)
Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.
